Category:ABA Keywords

From My wiki

Below are the key words and phrases from the 2008 through 2010 ABA inservice training (ITE) exams, followed by the percent of residents in their final year of training who answered the question pertaining to the key word correctly. Some (and soon, hopefully all) of these key words and phrases are discussed in detail on this site - click on the links to read more:

(note: please see our policy on Policy on Evidence Based Medicine and help us make these answers more robust by adding appropriate citations)

2-Chloroprocaine onset (45% in the year 2010)
Abdominal compartment syndrome: Diagnosis (74% in the year 2010)
ABG: Compensated respiratory acidosis (77% in the year 2010)
ABG: Pregnancy (60% in 2009)
ABG: COPD (81% in 2009)
ABG: morbid obesity and vomiting (73% in 2009)
ABG: opioid effect (74% in 2009)
ABG: pulm embolism (59% in 2009)
ABG: Respiratory acidosis/metabolic alkalosis (97% in the year 2010)
ABG: salicylate toxicity (92% in 2009)
Acetaminophen toxicity (84% in the year 2010)
Acetazolamide: mechanism of action (65% in 2008)
Acute hyperkalemia: treatment (66% in the year 2010)
Acute septic shock (76% in 2009)
Addiction: Definition (77% in the year 2010)
Addison disease: blood chemistry (52% in 2008)
Addison's disease: Perioperative treatment (70% in the year 2010)
Advanced multiple sclerosis: anesthetic drugs (69% in 2009)
Age-related P50 (98% in 2009)
Aging: Cardiovascular physiology (42% in the year 2010)
Aging: Pulmonary physiology (32% in the year 2010)
Air embolism Dx (65% in 2009)
Air embolism: Dx (81% in 2009)
Air embolism: treatment (98% in 2008)
Air trapping: Ventilator management (90% in the year 2010)
Airway assessment: Coexisting disease (94% in the year 2010)
Airway Anesthesia: Anatomy (66% in 2009)
Airway fire (56% in 2008)
Airway innervation (79.3% in 2008)
Airway: Pediatric vs Adult
Amiodarone: hemodynamic effect (49% in the year 2010)
Amiloride: physiologic effects (77% in 2008)
Amniotic fluid embolus:Dx (92% in 2009)
Anaphylaxis: Epinephrine treatment (90% in the year 2010)
Anemia compensation (65% in 2008)
Anes management: penetrating eye injury (87% in 2009)
Anes techniques: suspected MH (99% in 2009)
Anesthesia for ECT: lidocaine effect (35% in 2009)
Anesthesia: uterine muscle tone (90% in 2008)
Anesthesia techniques: 1st stage labor (83% in the year 2010)
Anesthesiologist drug abuse: Fentanyl (91% in the year 2010)
Anesthesiologists: substance abuse (85% in 2009)
Anesthetic absorption: regional anesthetic techniques (88% in 2008)
Anesthetic uptake: Right-to-left shunt (51% in the year 2010)
Anesthetic uptake: Solubility coefficient (66% in the year 2010)
Ankle block: anatomy (37% in 2008)
Anterior mediastinal mass: effects (87% in 2008)
Antithrombotic drugs: duration (87% in 2008)
Aortic clamping: ischemia mechanism (88% in 2008)
Aortic crossclamp: CV complications (65% in the year 2010)
Aortic insufficiency: Hemodynamic treatment (88% in the year 2010)
Aortic insufficiency: medical management (87% in 2008)
APGAR scoring (48% in 2008)
Arterial waveform: Peripheral vs. Central (65% in the year 2010)
ASA guidelines: sedation (99% in 2008)
ASA sedation guidelines (85% in 2009)
Ascites: PFT's (51.5% in 2008)
Aspirin toxicity: treatment (79% in 2008)
Aspirin: platelet effect (96% in 2008)
Asthma: Postpartum hemorrhage treatment (71% in the year 2010)
Atrial flutter: Pharmacologic treatment (37% in the year 2010)
Atlantoaxial instability: causes (96% in 2009)
Automated anesthesia record: Advantages (87% in the year 2010)
Automated vs. Paper Anesthesia Records (90% in 2009)
Automated vs. Paper Anesthesia Records (95% in 2009)
Autonomic Hyperreflexia: signs (63% in 2009)
Autonomic Hyperreflexia (82% in 2009)
Autonomic Innervation: upper extremity (87% in 2009)
Autonomic neurotransmitters (50% in 2009)
AV pacing: Hemodynamic effect (51% in the year 2010)
Axillary block limitations (74% in 2009)
Axillary block: complications (83% in 2009)
Axillary block: Median nerve rescue block (67% in the year 2010)
Benzodiazepines: respiratory effects (96% in 2008)
Beta-thalassemia: Newborn (97% in the year 2010)
Bicarb admin: CO2 effect (87% in 2009)
Bilateral carotid endarterectomy: Physiology (69% in the year 2010)
Blood brain barrier: Fluid transfer (78% in the year 2010)
Blood oxygen transport (59.5% in 2008)
Botox: pain relief mechanism (34% in 2009)
Bowel distention (95% in 2009)
Brachial artery catheter: Cx (78% in 2009)
Bradycardia during carotid surgery (82% in 2009)
Brain death pathophysiology (82% in 2009)
Brain: ketone metabolism (60% in 2008)
Bronchial blocker: Advantages (74% in the year 2010)
Bronchopleural fistula: Ventilator management (73% in the year 2010)
Bronchospasm: acute treatment (90% in 2008)
Bronchospasm: mechanical ventilation Dx (88% in 2009)
Bronchospasm triggers: ETT (82% in the year 2010)
Bupivacaine toxicity Rx (65% in 2009)
Burn management: carbon monoxide toxicity (59% in 2009)
Butyrylcholinesterase deficiency (72% in 2008)
Calcium chelation; transfusion (99% in 2009)
Calculation pulmonary vs systemic vascular resistance (84% in 2009)
Capnogram waveform: obstruction (61% in 2008)
Carbamazepine toxicity (74% in the year 2010)
Carbon monoxide poisoning: Rx (59% in 2009)
Carcinoid syndrome (69% in 2008)
Carcinoid crisis: treatment (67% in the year 2010)
Cardiac arrest: Induced hypothermia (74% in the year 2010)
Cardiac cycle: ECG (12% in the year 2010)
Cardiac morbidity: Pre-op factors (34% in the year 2010)
Cardiac surface anatomy (34% in 2008)
Cardiopulmonary bypass management (33% in 2009)
Carotid body: hypoxic drive (49% in 2009)
Carotid Endaterectomy: CNS monitoring (63% in 2009)
Cardiac pacemaker indications (61% in the year 2010)
Carotid sinus stim: post-heart transplant (76% in 2009)
Cardiac tamponade: Pulsus paradoxus (94% in the year 2010)
Carotid stent: Bradycardia cause (97% in the year 2010)
Carotid stent: Bradycardia prevention (97% in the year 2010)
Categorical data: Chi square test (52% in the year 2010)
Caudal anesthesia (67% in 2009)
Causes of upregualtions of NAChR (56% in 2008)
Celiac plexus block: complications (62% in 2008)
Celiac plexus block: complications (76% in 2009)
Celiac plexus block: indications (83% in 2008)
Celiac plexus block: Side effects (83% in the year 2010)
Central line infections: prevention (72% in 2009)
Cerebral Aneurysm clipping: anes management (58% in 2009)
Cerebral blood flow: Temperature effect (75% in the year 2010)
Cerebral ischemia: deep hypothermia (63% in 2009)
Cerebral vasospasm: treatment (82% in 2008, 70% in the year 201)
Cervical cerclage: Anesthetic management (66% in the year 2010)
Cervical fracture, Intubation techniques (75% in the year 2010)
Chi-squared test: appropriate data (46% in 2008)
Chloroprocaine metabolism (90% in 2009)
Chloroprocaine placental transfer (75% in 2009)
Chronic opioids: side effects (91% in 2009)
Chronic pain: cancer: methadone (68% in 2008)
Chronic pain: cancer: opioids (42% in 2008)
Circulator arrest: pH-stat implications (12% in the year 2010)
Cirrhosis: NMB kinetics (97% in 2009, 92% in the year 2010)
Clinical trial: study power (93% in 2008)
Closed claims: Brain damage (72% in the year 2010)
Clostridium tetani infection (15% in 2009)
CO from CO2 absorber (68% in 2008)
CO poisoning (65%, 75% in 2008)
CO poisoning: clinical features (54% in 2009)
CO poisoning: Diagnosis (71% in the year 2010)
CO toxicity: Treatment (28% in the year 2010)
CO2 absorbers: volatile anes toxicity (83% in 2009)
CO2 response curve (62% in 2008)
CO2 transport: bicarbonate (56% in 2009)
Compartment Syndrome: Dx (86% in 2009)
Congenital Long QT:management (16% in 2009)
Congenital Long QT:management (16% in 2009)
Congenital heart disease: Prostaglandin treatment (23% in the year 2010)
Congential heart disease: pulmonary hypertension treatment (74% in 2008)
Constrictive Pericarditis: Venous waveform (50% in 2009)
Coronary Artery: anatomy (81% in 2009)
Coronary perfusion pressure (95% in the year 2010)
Coronary perfusion pressure: L vs. R (27% in 2009)
CPB antifibrinolytics (73% in 2008)
CPRS I: early Sx (54% in 2009)
CRPS: diagnostic block (82% in the year 2010)
CPRS I: diagnosis (71% in 2009)
Craniotomy: positioning injury (73% in 2008)
CRPS II: treatment (54% in 2008)
Cryoprecipitate: fibrinogen content (86% in 2009)
Crystalloid resuscitation: coagulopathy (84% in 2008)
CV pharmacology: catecholamines (84% in 2008)
CV physiology: LV (52% in 2008)
CV physiology: mixed venous oxygen (52% in 2008)
Cylinder content: weight vs. pressure (86% in 2008)
Delayed emergence: differential diagnosis (74% in 2008)
Denervated heart: exercise physiology (77% in 2009)
Desmopressin for Von Willebrand (74% in 2009)
Diabetes insipidus intracranial surg (93% in 2009)
Diagnosis of croup (99% in 2008)
Diagnosis of obstructive sleep apnea (94% in 2008)
Differential spinal block (46% in 2008)
Difficult airway algorithm (93% in 2008)
Double lumen tube placement (85% in 2008)
Down's syndrome: abnormalities (98% in 2008)
Doxorubicin: Complications (87% in the year 2010)
Dx of Uterine rupture (37% in 2009)
Dural sac: Caudal extent (33% in the year 2010)
ECG loose lead effect (29% in 2009)
ECG leads: P-wave detection (83% in the year 2010)
ECT: anesthetic agensts and seizure duration (59% in 2008)
ECT: seizure duration (46% in 2008)
ECT: side effects (95% in 2009)
EEG: high dose opiates (34% in 2008)
Electrolyte Homeostasis: hormones (35% in 2009)
Elevated INR: Factor treatment (76% in the year 2010)
EMLA contraindications (47% in 2008)
Endobronchial intubation (64% in 2008)
Enoxaparin: assessment of effect (83% in 2008)
Enternal nutrition vs. TPN (93% in 2008)
Epidural anesthetics: respiratory effects (72% in 2009)
Epidural clonidine: mechanism of action (61% in 2008)
Epidural local anesthetic: peristalsis effect (63% in 2008)
Epidural test dose: Sx (88% in 2009)
Epiglottitis: anesthetic management (91% in the year 2010)
Epiglottitis: diagnosis (100% in 2008)
Epiglottitis: inhalation induction (65% in 2009)
Ethics: Speaker disclosure (91% in the year 2010)
Evoked potentials: anesthetic effects (55% in 2008, 83% in the year 2010)
EXIT procedure: Uterine atony (94% in the year 2010)
Factor VIII Concentrate: indications (93% in 2009)
Factors affecting turbulent flow (71% in 2009)
Factors causing prolonged neuromuscular blockade (81% in 2008)
Fat embolism: Dx (78% in 2009)
FB Aspiration: physical exam (73% in 2009)
Febrile transfusion reaction (40% in 2008)
Femoral Nerve Block anatomy (31% in 2009)
Femoral Nerve Block anatomy (49% in 2009)
Fenoldopam: Renal effects (55% in the year 2010)
Fetal blood gas values (78% in 2009)
Fetal HR pattern: Maternal hypotension (76% in the year 2010)
Fetal HR pattern: Normal labor (68% in the year 2010)
FFP: indications (26% in 2008, 60% in the year 2010)
FFP: warfarin reversal (94% in 2009)
Flowmeter: Gas properties (56% in the year 2010)
Fluid replacement in peds (97% in 2009)
Fluids: traumatic brain injury (84% in 2008)
FRC: definition (70% in the year 2010)
FRC: diseases effecting (89% in 2008)
FRC: Ventilatory setting effects (91% in the year 2010)
FV loop: mediastinal mass (66% in 2008)
Gas laws: temp/pressure changes (23% in 2009)
Gastric volume: breast milk vs. clear liquids (86% in 2008)
Geriatric anestheia: pulmonary changes (80% in 2008)
Geriatrics: NSAIDs use (96% in 2008)
Glasgow coma scale: definition (90% in 2009, 94% in the year 2010)
H2-blockers: Onset time (70% in the year 2010)
Haldane effect (41% in 2009)
HCTZ: mechanism of action (52% in 2008)
Head down position: hypoxemia (41% in 2009)
Heart block: Coronary occlusion (67% in the year 2010)
Heart transplant: autonomic effect (81% in 2009)
Heart transplant: autonomic pharmacology (85% in the year 2010)
Helium advantages: Small-bore tube (63% in the year 2010)
Hemodialysis effects (72% in 2008)
Hemodynamic effects of alpha blockers (84% in 2008)
Hemodynamics of laryngoscopy (59% in 2008)
Hemolysis: bilirubin levels (65% in 2009)
Hepatic dysfunction: Dx (67% in 2009)
Hepatic synthesis impairment: Diagnosis (71% in 2009, 45% in the year 2010)
Hepatic synthetic function: PT (82% in 2008)
Hepatitis B: Needle stick diagnosis (88% in the year 2010)
Herbal medicines: anticoagulation effects (64% in 2008)
Herbals: garlic (95% in 2009)
Herpes and pregnancy (62% in 2008)
Hetastarch: platelet function (82% in 2009)
HOCM: hypotension Rx (89% in 2009)
Hormonal stress response (51% in 2009)
Hydrochlorothiazide: Blood chemistry effects (24% in the year 2010)
Hyperaldosteronism: Drug treatment (93% in 2008)
Hyperbaric chamber: MAC effect (73% in the year 2010)
Hyperbaric Oxygen: indications (78% in 2009)
Hypercalcemia: Acute treatment (67% in the year 2010)
Hypercarbia: O2 release to tissues (78% in 2009)
Hyperglycemia: complications (81% in 2009)
Hyperglycemia: Preoperative treatment (88% in the year 2010)
Hyperkalemia: drugs causing (48% in 2009)
Hyperkalemia treatment (73% in the year 2010)
Hypermagnesemia treatment (67% in the year 2010)
Hyperparathyroidism: signs (31% in 2009, 33% in the year 2010)
Hypertension: brainstem injury (73% in 2008)
Hyperthyroidism: signs (37% in 2009)
Hypocalcemia: ECG effects (75% in the year 2010)
Hypoglycemia: glucagon (76% in 2008)
Hypothermia: Infant vs. toddler (79% in the year 2010)
Hypothermia: pH stat management (53% in the year 2010)
Hypovolemia signs: Pediatrics (8% in the year 2010)
Hypoxemia: closing capacity vs. FRC (90% in 2008)
Hypoxia during pneumonectomy: treatment (90% in the year 2010)
Hypoxemia: ventilator management (56% in 2009)
Hypoxic pulmonary vasodilation (27% in 2008)
IABP: Contraindications (86% in the year 2010)
ICP: tumor: corrected mechanism (57% in 2008)
ICU: enteral nutrition (83% in 2008)
IHSS: treatment (46% in 2009)
IHSS (85% in 2008)
Implantable cardiac defibrillator: interventions (36% in 2009)
Incompetent expiratory valve: Signs (80% in the year 2010)
Increased ICP: Acute treatment (38% in the year 2010)
Inhalational anesthesia: ventilatory effects (55% in 2009)
Inhaled anesthetics: vapor pressure (39% in 2008)
Interscalene block side effects (67% in 2008)
Intestinal obstruction: N2O (53% in 2008)
Intraoperative oliguria: hyperventilation (38% in 2008)
Intrascalene block: anatomy (57% in 2008)
Intravascular: extracellular volume ratio (47% in 2009)
Intubation in Pierre-Robin (76% in 2009)
Isoflurane: CMRO2 effect (88% in 2009)
Isovolemic hemodilution compensation (28% in 2008)
Joint commission: anesthesia standards (31% in 2008)
Ketamine analgesic mechanism (95% in the year 2010)
Ketamine: Pheochromocytoma (94% in the year 2010)
Ketamine receptor effects (82% in 2009)
Ketorolac: renal function (93% in 2009, 92% in the year 2010)
Lab assessment of renal function (3% in 2008)
Lambert-Eaton Syndrome: Physiology (73% in the year 2010)
Laparoscopy: ETCO2 (95% in 2008)
Laparoscopy: increased PaCO2 (91% in 2009)
Laryngospasm causes (97% in 2008)
Laryngospasm mechanism (40% in the year 2010)
Laryngospasm treatment options (65% in the year 2010)
Laser-safe endotracheal tubes (68% in the year 2010)
Latex allergy: Foods (50% in the year 2010)
Leukoreduction: Viral transmission (31% in the year 2010)
Line isolation monitor (25% in 2008)
Liposuction: lidocaine toxic dose (0% in 2008)
Lithotomy position: Nerve Injury (68% in the year 2010)
Local anesthetic: Methemoglobinemia (94% in the year 2010)
Local anesthetics: systemic toxicity (76% in 2008)
Local anesthetic: Transient neurologic symptoms (69% in the year 2010)
Low tidal volume ventilation: Protective effect (87% in the year 2010)
Lower extremity nerves: Sensory distribution (57% in 2008)
Lumbar nerve roots: Innervation (58% in the year 2010)
Lung protection ventilation: Pressure goal (58% in the year 2010)
Lung resection outcome: PFTs (9% in 2009)
LV failure: Diagnosis and treatment post-CPB (37% in the year 2010)
LV function: Geriatric (89% in the year 2010)
Magnesium complications (76% in 2009)
Magnesium: side effects Malignant hyperthermia: Associated disorders (25% in the year 2010)
Management: acute heart failure (66% in 2009)
Management: lumbosacral radiculopathy (71% in 2009)
Mannitol osmolarity effects (41% in 2009)
MAO inhibitor: meperidine toxicity (91% in 2009)
Mapleson D: Rebreathing (98% in the year 2010)
Mask CPAP: Physiologic effects (87% in the year 2010)
Maternal mortality causes (93% in 2009)
Maximum ABL calculation (62% in the year 2010)
Mecominum: Tracheal suctioning (79% in the year 2010)
Mediastinal tumor: Airway obstruction (92% in the year 2010)
Mediastinoscopy: vascular compression (85% in 2009)
Mediastinoscopy (79% in 2008)
Metabolic alkalosis: Respiratory compensation (79% in the year 2010)
Metformin/Contrast dye interaction (83% in 2009)
Methadone treatment management (98% in 2009)
Methemoglobinemia: diagnosis (78% in 2008)
Methemoglobinemia: Treatment (79% in the year 2010)
Methods: uterine relaxation (47% in 2009)
Metoclopramide: esophageal sphincter tone (79% in 2009)
Metoclopramide: gastric effects (95% in 2009)
MH vs. thyroid storm (91% in 2008)
Milrinone: CV effects (89% in the year 2010)
Milrinone: pharmacology (78% in 2009)
Mitral insufficiency: medical managmement (77% in 2008)
MOCA requirements (95% in 2009)
Monitoring for residual NMB (86% in 2009)
Monitoring: barbiturate coma (22% in 2008)
Morbid obesity: DVT (90% in 2008)
Morbid obesity: Hypoxemia physiology (43% in the year 2010)
Morbid Obesity: post-op complications (70% in 2009)
Morbid obesity: rapid desaturation (51% in 2009)
Morbidy obesity: PFT's (65% in 2008)
MRI: monitoring hazards (80% in 2009)
Multiple sclerosis: exacerbation (49% in 2009, 60% in the year 2010)
Muscle relaxation: Mechanism (59% in 2008)
Myasthenia: Muscle relaxant effects (41% in the year 2010)
Myasthenia gravis: postop management (27% in 2009)
Myasthenia gravis: postop management (68% in 2009)
Myasthenia: physiology (91% in 2008)
Myocardial O2 consumption: determinants (82% in 2009)
Myocardial ischemia: Acute MR (81% in the year 2010)
Myofascial pain: diagnosis (85% in 2008)
Myotonic dystrophy: Aspiration risk (76% in the year 2010)
Nalbuphine: Plateau effect mechanisms (73% in the year 2010)
Nasal fiberoptic intubation (83% in 2009)
Negative pressure pulmonary edema: Physiology (69% in the year 2010)
Neonatal bradycardia: treatment (68% in the year 2010)
Neonatal hypoxia: physiology (64% in 2008)
Neonatal resuscitation and meconium (71% in 2008)
Neonatal vs. adult cardiac physiology (67% in the year 2010)
Neonate: duration of post-anesthesia monitoring (35% in 2008)
Neostigmine: muscarinic effect (77% in 2008)
Nerve action potential termination mechanism (70% in the year 2010)
Nerve Block Landmarks (48% in 2009)
Nerve block: stimlation current vs. distance (52% in 2008)
Neuraxial anesthesia: cardiovascular effects (66% in 2009)
Neuraxial opioid action site (62% in the year 2010)
Neuraxial opioids: tolerance (86% in 2008)
Neuromuscular block: vecuronium (45% in 2009)
Neuromuscular blocking agents in CRF (97% in 2008)
Neuromuscular diseases: muscule pain (56% in 2009)
Neuromuscular disease: Succinylcholine hyperkalemia (67% in the year 2010)
Neuropathic pain: treatment (98% in 2008)
Neutral thermal environment: advantages (48% in 2008)
Nitroglycerin: Uterine relaxation (97% in the year 2010)
Nitroprusside toxicity: blood chemistry (35% in 2008)
Nitroprusside toxicity Treatment (25% in the year 2010)
Nitrous oxide: bowel distention (74% in 2008)
Nitrous Oxide: CBF and CMRO2 (35% in the year 2010)
NMB reversal: Assessment (60% in the year 2010)
NMB drug interactions (98% in 2009)
NMB in Eaton-Lambert syndrome (67% in 2008)
NMB/volatile agent interaction (62% in 2009)
NO hemodynamic effect (79% in the year 2010)
O2 delivery to fetus in labor (37% in 2009)
O2 delivery vs. PaO2 (21% in 2008)
O2 E cylinder (56% in 2008)
O2 release (87% in the year 2010)
Obesity: airway eval (64% in 2009)
Obstructive sleep apnea:Dx (85% in 2009)
Obstructive sleep apnea:Dx (85% in 2009)
Oculocardiac reflex management (99% in 2009)
Oculocardiac reflex: afferent path (52% in 2008)
Odds ratio calculation (61% in 2008)
Old MI: Preoperative risk assessment (68% in the year 2010)
Opioid neurotoxicity: treatment (47% in the year 2010)
Opioid Reversal (26% in 2009)
Oral Clonidine (84% in the year 2010)
Organ donor: bradycardia Rx (51% in 2009)
Organ donor: treatment of DI (89% in 2008)
Organophosphate poisoning: diagnosis and treatment (37% in 2008, 69% in the year 2010)
Osteomyelitis: diagnosis (87% in 2008)
Oxygen delivery index determinants (95% in 2009)
Oxygen saturation: PaO2 (71% in 2008)
Oxygenation during one-lung ventilation (63% in 2008)
Oxytocin: Electrolyte effects (39% in the year 2010)
P50 of hemoglobin: factors influencing (71% in 2008)
Pacer lead placement: ECG morphology (76% in the year 2010)
Pacemaker Designation (59% in 2009)
PACU bypass: Rationale (67% in the year 2010)
PACU bypass: Stage I bypass criteria (23% in the year 2010)
Pain management: rib fracture (76% in 2009)
Paired vs. unpaired t-test (64% in 2009)
PaO2: temperature correction (51% in 2008)
Paraplegia: Autonomic hyperreflexia (66% in the year 2010)
Parental presence: Indications (83% in the year 2010)
Patent ductus arteriosis: Diagnosis (36% in the year 2010)
PD of vecuronim in infants Peak vs. plateau airway pressure (76% in 2009)
PEEP to treat hypoxia (86% in 2009)
PEEP: Effect on PAOP (58% in the year 2010)
PEEP: Lung volume effect (30% in the year 2010)
PEEP: LV effects (14% in the year 2010)
Peripheral nerves: sensory vs motor (82% in 2009)
Peripheral oxygen delivery (30% in 2008)
Peripheral TPN complications (51% in 2009)
pH buffering: Bicarbonate (89% in the year 2010)
Pheochromocytoma: Dx markers (47% in 2009)
Pheochromocytoma hypertension treatment (33% in the year 2010)
Pheochromocytoma: preop preparation (84% in 2009)
Physician impairment: Referral (63% in the year 2010)
Pituitary adenoma: deficiencies (89% in 2008)
Placenta accreta: Risk factors (66% in the year 2010)
Placental transfer: anticholinergic (70% in 2009)
Placental transfer: local anesthetics (79% in 2009)
PONV: Peds vs. adults (89% in the year 2010)
PONV after pediatric surgery (97% in 2009)
PONV prophylaxis (81% in 2009)
Post-cardiac transplant patient (74% in 2008)
Post-CPB creatinine increase: Differential diagnosis (85% in the year 2010)
Post-dural puncture headache: risk factors (91% in the year 2010)
Postherpetic neuralgia: risk factors (53% in 2008)
Postoperative apnea: post conceptal age (40% in 2008)
Postoperative ATN: Differential diagnosis (74% in the year 2010)
Postoperative jaundice: Differential diagnosis (58% in the year 2010)
Postoperative oliguria: cause (76% in 2008)
Power analysis: Study design (90% in the year 2010)
Pre-term labor: treatment (51% in 2009)
Preeclampsia: Lab abnormalities (78% in the year 2010)
Pregnancy: asthma (78% in 2008)
Pregnancy: gastric function (57.5)% in 2008
Pregnancy: GE reflux mechanism (90% in the year 2010)
Pregnancy: hemodynamic effects (87% in 2008)
Pregnancy: Hematologic changes (85% in the year 2010)
Pregnancy: inhalation induction (91% in 2008)
Pregnancy: laboratory measurements (71% in 2008)
Pregnancy: non-OB surg risks (73% in 2009)
Pregnancy: SVT Rx (47% in 2009)
Preoperative anxiolysis in children (51% in 2009)
Preoperative renal failure predictors (61% in the year 2010)
Preoperative testing: Bayes theorem (64% in the year 2010)
Preoptic anterior hypothalamus: diagnosis (94% in 2008)
Prerenal oliguria: dx (71% in 2009)
Pressure vs. volume ventilation: ICU (94% in the year 2010)
Propofol Infusion syndrome: Dx (27% in 2009)
Prostaglandin for congenital heart: Dx (18% in 2009)
Pseudocholinesterase synthesis (87% in 2008)
Pulmonary embolism (77% in 2008)
Pulmonary function: ALS (95% in 2008)
Pyloric stenosis: metabolic abnormality (94% in the year 2010)
QT prolongation with antiemetics Radiculopathy: steroid epidural (65% in 2008)
Recovery of neuromuscular function in different muscles (43% in 2008)
Recurrent laryngeal nerve injury (85% in 2008)
Refractory hemophilia (53% in 2008)
Refusal of blood transfusion (65% in 2008)
Regional anesthetic: foot surgery (51% in 2008)
Regional anesthetics: low molecular weight heparin (90% in 2008)
Renal Failure: CPB surgery (78% in 2009)
Renal failure: electrolytes (64% in 2009)
Renal failure: electrolytes (64% in 2009)
Renal failure: periop preservation (93% in 2009)
Renal failure: platelet function (58% in 2009)
Renal failure: relaxants (91% in 2009)
Renal insufficiency: Dx (38% in 2009)
Renal insufficiency: hyperkalemia (44% in 2009)
Renal replacement therapy: Patient selection (82% in the year 2010)
Renal transplant: mannitol (54% in 2008)
Renin-angiotensin CV physiology (77% in the year 2010)
Respiratory alkalosis: renal compensation (49% in 2008)
Respiratory distress syndrome: effects (peds) (68% in 2008)
Restrictive lung disease: diagnosis (96% in 2008)
Restrictuve lung disease: diagnosis (96% in 2008)
Retrobulbar vs. peribulbar block (66% in 2008)
Rheumatoid arthritis complications (52% in 2009)
Ritodrine: effects (28% in 2008)
Robotic prostatectomy: contraindications (66% in 2009)
Root cause analysis: Essential elements (83% in the year 2010)
Rx: Antithrombin 3 deficiency (82% in 2009)
Saline: hyperchloremic acidosis (97% in the year 2010)
Saphenous nerve damage: signs SBE prophylaxis (45% in 2009)
SE vs. SD calculation (9% in the year 2010)
Septic shock therapy (97% in 2008)
Septic shock: stress response mediators (55% in 2008)
Septic shock: Vasopressin treatment (78% in the year 2010)
Shunt: effect of increased FiO2 (48% in 2009)
SIADH: lab findings (49% in 2008, 84% in the year 2010)
Side effects of tocolytics (47% in 2009)
Sitting position: BP measurement (93% in the year 2010)
Smoking cessation: acute physiology (63% in 2009)
Smoking cessation respiratory physiology (90% in the year 2010)
Somatic pain vs. visceral pain (88% in 2008)
Spinal aneshetics: neonatal indications (76% in 2008)
Spinal anesthetics: anatomy (51% in 2008)
Spinal anesthetics: severe bradycardia (46% in 2008)
Spinal anesthetics: transient neurologic symptoms (86% in 2008)
Spinal ansthesia complications (66% in 2008)
Spinal anesthesia complications: MRI indications (98% in the year 2010)
Spinal anesthesia spread: Factors (73% in the year 2010)
Spinal cord anatomy (52% in 2008)
Spinal cord: blood flow (32% in 2008)
Spinal cord stimulator: Reprogramming (77% in the year 2010)
Spinal hypotension: treatment (97% in the year 2010)
Spinal stenosis: Diagnosis (90% in the year 2010)
SpO2 effect of methemogoblin (88% in 2009)
SSEP latency: anesthetic drugs (68% in 2009)
SSEP: physiological effects (59% in 2008)
Statistical analysis: power (99% in 2009)
Statistics: ANOVA indications (79% in the year 2010)
Statistics: median (89% in 2009)
Stellate ganglion block: effects (60% in 2008)
Stellate ganglion block: effects (70% in 2009)
Steroid prophylaxis indications (63% in 2009)
Stroke volume: Atrial fibrillation effects (72% in the year 2010)
Study design: blinding (78% in 2008)
Subarachnoid bleed: ECG effects (62% in the year 2010)
Subarachnoid hemorrage: nimodipine (87% in 2009)
Subdural injection: symptoms (62% in 2008)
Succinylcholine contraindications (92% in 2008)
Succinylcholine and bradycardia (91% in 2009)
Succinylcholine in Guillain Barre Syndrome (29% in 2008)
Succinylcholine: lower esophageal sphincter pressure (52% in 2008)
Succinylcholine: Normal K increase (58% in the year 2010)
Surgery risk during pregnancy (84% in 2008)
Superior laryngeal nerve anatomy (80% in the year 2010)
Surgical stimulation: Effect on MAC (69% in the year 2010)
SVO2 physiology (80% in 2009)
Sympathetic block indications (20% in 2009)
Synchronized electrical cardioversion (68% in 2009)
Systemic Effects of Ketamine (unknown)
TEE views: perfusion distribution (22% in 2008)
TEE: diagnosis: hypotension TEF: Other abnormalities (70% in the year 2010)
Tension pneumothorax: Dx and Rx (95% in 2009, 77% in the year 2010)
Tetralogy of Fallot Rx (82% in 2009)
Thiopental: CMRO2/CBF relationship (86% in the year 2010)
Thiopental theraputic coma (79% in 2008)
Thoracoscopy: Hypoxemia treatment (42% in the year 2010)
Thyroidectomy: complications (47% in 2008)
Thyroidectomy: hypocalcemia (77% in 2009, 67% in the year 2010)
Time constant definition (13% in 2009)
Total knee replacement: Regional anesthesia techniques (82% in the year 2010)
TPN discontinuation: hypoglycemia (88% in 2009)
TPN discontinuation complications (90% in the year 2010)
TPN: metabolic effects (96% in 2009)
TPN: phophorous deficiency (42% in 2008)
Transcutaneous pacing (74% in 2008)
Transdermal fentanyl indications (93% in 2009)
Transfusion: bacterial sepsis (84% in 2008)
Treatment of increased ICP (98% in 2008)
Trigeminal neuralgia: Rx (73% in 2009)
TRALI: Treatment (48% in the year 2010)
Transfusion mortality: Causes (47% in the year 2010)
Traumatic Brain Injury: CPP (33% in the year 2010)
Trigger point injections indications (89% in 2009)
Tumescent liposuction: lidocaine dose (28% in 2009)
Tumescent liposuction complications (33% in the year 2010)
TURP syndrome: Treatment (54% in the year 2010)
Type and Screen (unknown)
Type I statistical error: definition (80% in 2008)
Ultrasonography: internal jugular (93% in 2008, 93% in the year 2010)
Ultrasound structures: echogenicity (70% in 2009)
Uncuffed ETT: Max leak pressure (81% in the year 2010)
Unilateral blindness: etiology (95% in 2009)
Unilateral blindness: etiology (95% in 2009)
Upper extremity nerve blocks: indications (98% in 2009)
Upper extremity regional management (32% in 2008)
Upper extremity tourniquet pain prevention (73% in the year 2010)
Uptake and distribution: infant vs. adult (53% in 2008)
Uptake of inhaled anesthetics: V/Q mismatch (37% in 2009)
Uterine atony (98% in 2008)
Uterine rupture: Diagnosis (48% in the year 2010)
Uterine relaxation techniques (91% in 2008)
V/Q mismatch - emphysema (44% in 2009)
Vapor pressure: volatile agents (26% in 2008)
Vaporizer output at altitude (75% in 2008)
Vaporizer output calculation (25% in the year 2010)
Vasodilator pharmacokinetics (46% in 2009)
Vasodilators: renal blood flow (78% in 2009)
Vasopressin Rx diabetes insipidus (55% in 2009)
Vasopressin:pharmacology
Vasopressors: risk of myocardial ischemia (90% in 2009)
VE/PaCO2 relationship: Hypoxia (53% in the year 2010)
Venous air embolism (45% in 2009)
Venous air embolism: Detection (87% in the year 2010)
Ventilation modes: Pressure waveform (74% in the year 2010)
Ventilator disconnect: Detection (72% in the year 2010)
Ventilator settings: atelectasis (74% in 2008)
Ventilator: low tidal volume (87% in 2009)
Ventricular hypertrophy (72% in 2008)
Ventricular PV loops (76% in 2009)
Ventricular PV loops (76% in 2009)
Verapamil dantrolene interaction (56% in 2008)
VF: Epinephrine mechanism (28% in the year 2010)
Wall oxygen failure: Signs (53% in the year 2010)
WHO analgesic ladder (50% in the year 2010)
Work of breathing: Neonate vs. adult (49% in the year 2010)